WeR1's Client SGX-Listed Sasseur REIT Wins Top IR Award For Second Consecutive Year
Sep 30, 2020 13:00 HKT |  |
|
宏基資本建議購回最多102,000,000股股份 要約價每股0.68港元 較最後交易日收市價溢價51.11%
Sep 29, 2020 09:01 HKT | |
|
Rykadan Capital Proposes Stock Buy-back of Up to 102,000,000 Shares at Offer Price of HK$0.68 Per Share, Equivalent to 51.11% Premium over the Closing Price on the Last Trading Day
Sep 29, 2020 09:00 HKT | |
|
Tiger Brokers adds ASX to its Online Trading & Mobile App
Sep 18, 2020 13:30 HKT |  |
|
Tiger Brokers Singapore Adds ASX to its Online and Mobile Trading Apps, Addressing Demand from Investors
Sep 17, 2020 15:00 HKT | |
|
HKTDC Export Index 3Q20: Exporter confidence rises for second consecutive quarter
Sep 14, 2020 18:00 HKT |  |
|
Greenbriar Capital Corp Reports $2,771,759 or $0.12 per Share of Net Income in Q2 2020
Sep 03, 2020 04:00 HKT |  |
|
Compagnie Financiere Tradition SA Acquires 100% of OM Wholesale in New Zealand
Sep 02, 2020 08:00 HKT |  |
|
Singapore's Elite Partners Acquires Warehouse in Poland for over EUR30 Million (S$48.6 Million) from Subsidiary of Sovereign Fund GIC
Aug 31, 2020 11:00 HKT |  |
|
禹洲集团(01628.HK)上半年收入按年升20.4%至逾140亿人民币 派发中期息每股12港仙
Aug 25, 2020 13:33 HKT | |
|
禹洲集團(01628.HK)上半年收入按年升20.4%至逾140億人民幣 派發中期息每股12港仙
Aug 25, 2020 13:32 HKT | |
|
Nathan's Famous Partners With UAE Based Mezzan Group to Manufacture Halal Hot Dogs
Aug 15, 2020 13:00 HKT |  |
|
Inaugural 'Standard Chartered GBA Business Confidence Index'
Jul 23, 2020 18:00 HKT | |
|
Greenbriar Comments on Recent Controversy on Social Media
Jul 23, 2020 13:00 HKT | |
|
Episode Six Secures $7 Million to Accelerate Global Growth as Demand for Digital Transformation Increases
Jul 21, 2020 21:00 HKT |  |
|
伯克哈德·迪克教授正式加入德视佳眼科国际医学顾问委员会
Jul 15, 2020 14:23 HKT | |
|
伯克哈德·迪克教授正式加入德視佳眼科國際醫學顧問委員會
Jul 15, 2020 14:22 HKT | |
|
Dr. Burkhard Dick Joins the EuroEyes International Medical Advisory Board
Jul 15, 2020 14:21 HKT | |
|
Greenbriar Executes a Master Sales and Marketing Agreement with Keller Willams - Paul Morris Forward Living Inc
Jul 13, 2020 06:00 HKT | |
|
AIM ImmunoTech(AIM)与Roswell Park综合癌症中心签署临床试验协议，支持Ampligen联合干扰素Alfa-2b治疗感染COVID-19的癌症患者的1/2期临床试验
Jul 10, 2020 08:00 HKT |  |
|